NeuBase Therapeutics (STU:O7P) Other Operating Expense : €0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is NeuBase Therapeutics Other Operating Expense?

NeuBase Therapeutics's Other Operating Expense for the three months ended in Sep. 2023 was €0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 was €0.00 Mil.

NeuBase Therapeutics's quarterly Other Operating Expense declined from Mar. 2023 (€0.00 Mil) to Jun. 2023 (€0.00 Mil) but then increased from Jun. 2023 (€0.00 Mil) to Sep. 2023 (€0.00 Mil).

NeuBase Therapeutics's annual Other Operating Expense increased from Sep. 2019 (€-0.00 Mil) to Sep. 2020 (€0.00 Mil) but then declined from Sep. 2020 (€0.00 Mil) to Sep. 2021 (€-0.00 Mil).

NeuBase Therapeutics Other Operating Expense Historical Data

The historical data trend for NeuBase Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuBase Therapeutics Other Operating Expense Chart

NeuBase Therapeutics Annual Data

Trend

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Other Operating Expense

Get a 7-Day Free Trial

0.98

0.97

NeuBase Therapeutics Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

NeuBase Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

NeuBase Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of NeuBase Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

NeuBase Therapeutics (STU:O7P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeuBase Therapeutics Inc (STU:O7P) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

NBSE:USA O7P:Germany

Address

350 Technology Drive, Suite 421, Pittsburgh, PA, USA, 15219

Website

https://www.neubasetherapeutics.com

NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.

NeuBase Therapeutics (STU:O7P) Headlines

No Headlines